The company's stock is in the consolidation stage strongly
The stock is now buy
I do not recommend Stop Loss because you will be taken out by the market makers
I cannot say more details about my strategy as it is very confidential
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage...
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage...
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage...
This is a signal that APTO's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options. I looked back and found 29 similar cases where APTO's RSI Indicator left the oversold zone, and in 25 of them led to a successful outcome. Odds of Success: 86%.
APTO is a cool little company ive had shares of for a few years now.
Do some research on their drugs coming out, TONS of potential.
Not too much to say right now as indicatore running flat with no volume. Settleing in around the .5 fib line nicely. Could jump up or down at any point.
Long term hold for me, as the upside could be very big if the CG-806...
APTO Buy and Sell zones on a trend reversal could be cup and handle obviously a double bottom.
If it holds this higher uptrend support and not the channel a breakout is still a buy above obviously
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5,...
